Category: OcuMedic

Prolonged Ocular Therapy

OcuMedic, Inc. and Gelest, Inc. Enter Investment and Supply Agreement for Novel Contact Lens Drug Delivery System

Gelest exclusive supplier of chemistry for OcuMedic proprietary drug eluting contact lens and corneal bandage MULLICA HILL, NJ (October 9, 2019) – OcuMedic, Inc., the developer of new proprietary , drug-eluting soft contact lens/clear corneal bandage technology to replace eye drops, today announced it has entered into an exclusive supply agreement and received a strategic …

Dr. Paul Karpecki Named Lead Optometric Advisor for OcuMedic, Inc.

Dr. Karpecki, a leading corneal health researcher, to assume key role on Company’s Scientific Advisory Board MULLICA HILL, NJ (September 20, 2018) – OcuMedic, Inc., the developer of new, drug-eluting soft contact lens and clear corneal bandage technology, today announced the appointment of Paul Karpecki, OD, FAAO, as the company’s lead optometric advisor and member …

OcuMedic invited presentation for BIO

BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the …

New Drug-eluting Contact Lens to Provide Timed Drug Delivery Directly to Eye; Improving Recovery, Reducing Cost for Millions after Eye Surgery and LASIK

Published: May 15, 2018 MULLICA HILL, N.J.–(BUSINESS WIRE)– New, drug-eluting soft contact lens technology, has shown to deliver a number of different drugs directly to the eye and may soon improve post-operative recovery for millions of people who undergo cataract and LASIK surgery or suffer corneal abrasions every year. The new, extended-wear contact, developed by …